The increased focus on precision medicine holds tremendous promise to more effectively target treatments to those individuals most likely to have a benefit. However there are a number of regulatory science challenges to ultimately develop and utilize personalized medicine technologies and approaches. The objective of this second annual Forum is to bring together federal agencies, industry, foundations and academic institutions, to help identify and address some of the key topics and opportunities for regulatory science to advance precision medicine. Ultimately, the goal is to advance precision medicine by identifying and addressing regulatory science gaps, informing regulatory decision-making, and developing educational resources
The Regulatory Science to Advance Precision Medicine Working Group has finalized the following topic for the 2018 Fall Forum:
Digital health, particularly the emerging role of software (algorithms and data analytics approaches) and sensors in precision medicine. The Forum will examine areas of emerging science, regulatory considerations, ethics and privacy, data storage and use, including use as real world data and patient reported outcomes.
There is no cost to attend the Forum, which is sponsored by the University of Rochester Clinical and Translational Science Institute (CTSI) and the PhRMA Foundation.
Registration is required, as space is limited. If you would like to register or have any questions, please contact Scott Steele (Scott_Steele@URMC.Rochester.edu) or Joan Adamo (Joan_Adamo@URMC.Rochester.edu).